Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 September 2022 | Story André Damons | Photo Jack once productions
The three directors of Epicutis Skincare
All smiles. The three directors of Epicutis Skincare; Dr Maanda Tshikororo, Chief Marketing Officer; Dr Lehlohonolo Makhakhe, Chief Executive officer and primary formulation scientist; and Mrs Mantwa Makhakhe, Chief Operating Officer, showing of some of their new skincare products

A senior lecturer and specialist in the Department of Dermatology at the University of the Free State (UFS) and his two associates, who are also postgraduate students at the university, have realised their dream when they launch their skincare company next month.
 

Dr Lehlohonolo Makhakhe, a full-time medical specialist (dermatologist), Dr Maanda Tshikororo, a medical doctor and a postgraduate student in the Department of Psychiatry, and Mrs Mantwa Makhakhe, who holds a BCom Economics degree and is currently completing her postgraduate diploma in financial planning, are the directors of Epicutis Skincare. Dr Makhakhe, who is also a PhD candidate registered with UFS, is the Chief Executive Officer and primary formulation scientist for the company, while Dr Tshikororo is the Chief Marketing Officer and Mrs Makhakhe the Chief Operating Officer.

The company is launching on 22 October 2022.

Narrowing the gap between treating skin ailments and manufacturing skincare products

According to Dr Makhakhe, who published the very first comprehensive African atlas on skin diseases commonly seen in the African setting,The African Atlas, synopsis and practical guide to clinical dermatology, says Epicutis is a company which will produce a range of personal skincare products. The range will comprise of products such as body lotions, body creams, petroleum jelly and a night cream. Since becoming a dermatologist, he has always wished to narrow the gap between being a clinician treating skin ailments and being involved in manufacturing skincare products.

“Creating products as a dermatologist has great benefits, because the products are created from a clinician’s perspective, with more intentional results. All ingredients used were carefully selected for their specific and scientifically proven benefits, they were then tested for stability in terms of viscosity, pH, microbiology in association with the South African Institute of Dermatology and other third parties,” says Dr Makhakhe. 

Ecstatic about the upcoming launch

Dr Tshikororo says this has been an adventure they have always thought of undertaking. “We finally reached a point of shifting from the comfort of dreaming about it, to taking action.” 

“We hope our company will play a notable role in creating permanent employment for the youth, and also have an impact on the growth of the economy of the Free State province and that of the country as well,” says Mrs Makhakhe. 
The three directors are ecstatic about the upcoming launch of their products, and optimistic that there is enough room for new, affordable, locally manufactured skincare products that are suitable for all family members.  

All products will be available at major retailers soon after the launch. Further information is available at the official website

News Archive

Chakalaka can have side effects for these patients
2010-06-24

Chakalaka is a sauce many South Africans cannot imagine a meal without, but research at the Faculty of Health Sciences at the University of the Free State (UFS) has shown that it can have serious side effects and even compromise the treatment of leukaemia patients.

Prof. Vernon Louw from the Department of Internal Medicine at the Faculty says that tyrosine kinase inhibitors (TKIs) are a new group of drugs providing targeted therapy for chronic myeloid leukaemia (CML). It vastly contributes to the survival of patients, but it has side effects like vasodilatation. Research has shown that spices like chakalaka may aggravate vasodilatation (widening of veins) with patients on these drugs.

“These spices produce serious oedema (water retention) and headaches. We have found that discontinuing the intake of spices allows some patients to maintain therapeutic doses of TKIs.” Chakalaka contains mainly garlic and chilli.

CML represents up to 20% of all leukaemia patients in South Africa and up to 450 new cases are reported every year.

In the study symptoms of severe headache and oedema disappeared within days of discontinuing the use of chakalaka.

Prof. Louw says it is important for oncologists to ask their patients about their intake of spices and garlic when they are on TKIs. It is also advisable to enquire about the use of complementary alternative medicine as the interaction of these medicines in cancer treatment is not known.

Media Release

Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za
23 June 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept